Vip Pharmaceuticals Private Limited

Vip Pharmaceuticals Private Limited - pharma in New, Delhi, India. FY 2026 financials & compliance.
CIN U24239DL2000PTC107962 Incorporated 29 September 2000 ROC Delhi HQ New, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹40.07 Cr
▲ 6% YoY
Net profit · FY 2025
₹1.51 Cr
Net margin 3.8%
EBITDA · FY 2025
₹2.81 Cr
EBITDA margin 7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹8.98 Lakh
Issued & subscribed
Open charges
₹2.99 Cr
Satisfied ₹1.13 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
21
Provident fund records

About Vip Pharmaceuticals Private Limited

Data last updated:

Vip Pharmaceuticals Private Limited is a private limited company based in New, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 September 2000 and has been in existence for over 26 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2000PTC107962. Its GSTIN is 07AABCV3751D2ZJ (Delhi). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.98 Lakh. It is led by directors Deepak Kumar and Sunita Rani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B 6 7 Gali No 13 Madhu Vihar, New, Delhi, India – 110002.

As per the financials filed for FY 2025, the company reported a revenue of ₹40.07 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Cr (net margin 3.8%) and EBITDA of ₹2.81 Cr (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 18% over five years.

The company has about 21 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: VIP Pharmaceuticals. As per MCA filings, the company has open charges of ₹2.99 Cr and satisfied charges of ₹1.13 Cr on record. Court records list 15 cases involving the company, including 5 filed by the company and 10 filed against it; 4 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vippharma.co.in.

Company Details of Vip Pharmaceuticals Private Limited
CIN U24239DL2000PTC107962
Registration Number 107962
Incorporation Date 29 September 2000
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    B 6 7 Gali No 13 Madhu Vihar, New, Delhi, India – 110002
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Vip Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Vip Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Vip Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with Vip Pharmaceuticals Private Limited

Vip Pharmaceuticals operates one associated brand: VIP Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures pharmaceutical formulations, offers branded generics and contract manufacturing services globally.vippharma.co.in

Competitors & Alternatives of Vip Pharmaceuticals Private Limited

Brands and companies operating in the same space as Vip Pharmaceuticals Private Limited include Pharmaron, Pfizer, Lonza and 6 more.

CompetitorDescriptionLocationFounded
Pharmaron Pharmaron Drug discovery and development services for small molecules are provided.Beijing, China2003
Pfizer Pfizer Pharmaceutical products for treating multiple diseases are provided.New York, United States1849
Lonza Lonza CDMO services for pharma, biotech, and specialty ingredients are provided.Basel, Switzerland1897
Dotmatics Dotmatics AI powered scientific data management and workflow automation solutions2005
Boehringer Ingelheim Boehringer Ingelheim Generic drugs and clinical research services are provided globally.1885
LabConnect LabConnect Laboratory testing, clinical trial research, and biopharma services are provided.Johnson City, United States2002
Beta Drugs Beta Drugs Developer of therapeutics for oncology and dermatologyPanchkula, India2005
Ainos Ainos Novel point-of-care testing and low-dose interferon therapeutics are developed.San Diego, United States1986
Biomatter Biomatter Provider of synthetic biology and AI-based technology for generative protein designVilnius, Lithuania2018

Business Activity of Vip Pharmaceuticals Private Limited

The main business activity of Vip Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Vip Pharmaceuticals Private Limited

Vip Pharmaceuticals Private Limited is audited by VISHWA MITTER & CO for the financial year 2020.

NameStatusAppointment DateCessation Date
VISHWA MITTER & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Vip Pharmaceuticals Private Limited

Vip Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Deepak KumarDirector01 Sep 20224 Years 1 MonthsCurrent
Sunita RaniAdditional Director07 Mar 20251 Years 7 MonthsCurrent

Financials of Vip Pharmaceuticals Private Limited FY 2025 filings available

Vip Pharmaceuticals Private Limited reported revenue of ₹40.07 Cr (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹40.07 Cr ▲ 6%
Net profit · FY 2025
₹1.51 Cr margin 3.8%
EBITDA · FY 2025
₹2.81 Cr margin 7%

Compounded Annual Growth Rate (CAGR) of Vip Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 17%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 23%
5 years · compounded
▲ 20%

Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 6% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Vip Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹2.81 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.51 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Vip Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7%••••••••••••••••
Net Profit Margin3.8%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vip Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Vip Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Vip Pharmaceuticals Private Limited

Open charges
₹2.99 Cr
Satisfied charges
₹1.13 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹2.99 Cr
Latest charge details
DateLenderAmountStatus
16 Apr 2022Hdfc Bank Limited₹2.99 CrOpen
19 Feb 2015Vijaya Bank₹60 LakhSatisfied
14 Aug 2007Vijay Bank₹30 LakhSatisfied
07 Apr 2006Vijay Bank₹14 LakhSatisfied
06 Mar 2001Bank of Baroda₹8.5 LakhSatisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Vip Pharmaceuticals Private Limited

Vip Pharmaceuticals Private Limited has a workforce of 21 employees as of Apr 06, 2024.

Employee count
21
Active EPFO establishments
1
Employee growth
-25%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Vip Pharmaceuticals Private Limited

Vip Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AABCV3751D2ZJDelhiActive08 Mar 2020
02AABCV3751D1ZUHimachal PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Vip Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Vip Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Vip Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Vip Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Vip Pharmaceuticals Private Limited

Activity
30 Sep 2025
Vip Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Vip Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Directors
07 Mar 2025
Sunita Rani was appointed as a Additional Director on 07 Mar 2025 & has been associated with this company since 1 year 7 months.
Directors
01 Sep 2022
Deepak Kumar was appointed as a Director on 01 Sep 2022 & has been associated with this company since 4 years 1 month.
Charges
16 Apr 2022
A charge with Hdfc Bank Limited amounted to Rs. 298.50 Lakh with Charge ID 100560181 was registered on 16 Apr 2022.
Charges
28 Jun 2021
A charge registered on 06 Mar 2001 via Charge ID 90048372 with Bank Of Baroda was fully satisfied on 28 Jun 2021.

Frequently Asked Questions about Vip Pharmaceuticals Private Limited

Vip Pharmaceuticals is an active private limited company based in New, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 September 2000 (26+ years old) and is registered under CIN U24239DL2000PTC107962.

Vip Pharmaceuticals reported revenue of ₹40.07 Cr for FY 2025 (up 6% YoY).

Vip Pharmaceuticals has 2 current directors:

Vip Pharmaceuticals reported a net profit of ₹1.51 Cr (net margin 3.8%) and EBITDA of ₹2.81 Cr (EBITDA margin 7%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Vip Pharmaceuticals is 17% over three years and 18% over five years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Vip Pharmaceuticals is 07AABCV3751D2ZJ, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 02AABCV3751D1ZU (Himachal Pradesh).

The CIN (Corporate Identification Number) of Vip Pharmaceuticals is U24239DL2000PTC107962. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Vip Pharmaceuticals has 15 court cases on record: 5 filed by the company and 10 filed against it. 4 are pending. Most are in the district courts.

Vip Pharmaceuticals was incorporated on 29 September 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available